login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ANAVEX LIFE SCIENCES CORP (AVXL) Stock News
USA
- NASDAQ:AVXL -
US0327973006
-
Common Stock
8.1
USD
-0.39 (-4.59%)
Last: 10/28/2025, 8:00:01 PM
8.0866
USD
-0.01 (-0.17%)
After Hours:
10/28/2025, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
AVXL Latest News, Press Relases and Analysis
All
Press Releases
7 days ago - By: Stocktwits
Anavex Life Sciences Stock Sparks Retail Banter On Hopes Of EMA Conditional Nod For Alzheimer's Drug, Big Pharma Tie-Up
19 days ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences Announces Presentation at the 35th Alzheimer Europe Conference ‘Connecting Science and Communities: The Future of Dementia Care’
a month ago - By: Stocktwits
- Mentions:
EAOR
ITOT
Anavex Life Sciences Stock Just Shot Up 7% Today – Here’s An Important Update
a month ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences Announces Successful Development of Once-Daily Oral Tablet Formulation for the ANAVEX®3-71 Program
2 months ago - By: Stocktwits
- Mentions:
EAOR
VTWG
Anavex Life Sciences Stock Rises After Experimental Alzheimer’s Drug Slows Cognitive Decline In Study
a month ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences Announces Positive Topline Results from Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia
a month ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences Announces Publication of Oral Blarcamesine Describing a New Class of Clinical Precision Medicine from Phase IIb/III Alzheimer’s Disease Trial
2 months ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences Announces Oral Blarcamesine Cognitive Resilience Results Approximating Normal Aging in New Precision Medicine Clinical Data from Phase IIb/III Alzheimer’s Disease Trial
2 months ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference 2025
2 months ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences Reports New Publication in Medical Journal Highlighting the Established Precise Autophagy Mechanism with Blarcamesine
3 months ago - By: Benzinga
What to Expect from Anavex Life Sciences's Earnings
4 months ago - By: Stocktwits
Anavex Life Sciences Stock Falls After Hours On $300M Raise Plan; Retail Traders Think It’s A ‘Smart’ Move
2 months ago - By: Benzinga
Anavex Life Pre-Treatment Prevented Cognitive Impairment In Animal Model of Alzheimer's Disease, New Publication Shows
2 months ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences Announces New Publication in Medical Journal: Blarcamesine Prevented Cognitive Impairment in Animal Model of Alzheimer’s Disease
3 months ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences Reports Fiscal 2025 Third Quarter Financial Results and Provides Business Update
3 months ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences to Announce Fiscal 2025 Third Quarter Financial Results on Tuesday, August 12, 2025
3 months ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences Announces Positive Precision Medicine Results from up to 4-Years of Oral Blarcamesine Treatment in Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease
4 months ago - By: Stocktwits
- Mentions:
BULL
SBET
BBAI
OSCR
Top 5 Trending Stocks On Stocktwits Today: Webull, SharpLink, Anavex Life Sciences, BigBear.ai, And Oscar Health
6 months ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences to Participate at Upcoming Healthcare Conferences
6 months ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences Reports Fiscal 2025 Second Quarter Financial Results and Provides Business Update
6 months ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences to Announce Fiscal 2025 Second Quarter Financial Results on Tuesday, May 13, 2025
6 months ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences Announces Full Enrollment of Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia
6 months ago - By: Anavex Life Sciences Corp.
Anavex Life Sciences to Participate in The Citizens Life Sciences Conference
Please enable JavaScript to continue using this application.